The timing of events that guide cells through the various stages of cell growth and division necessarily depends on the synthesis or activation of proteins that specify one cell cycle stage coupled with the inactivation or degradation of proteins that specified the previous cell cycle stage. In recent years, it has become apparent that the ubiquitin (Ub)-dependent proteolytic system plays an important role in regulating the steadystate levels of a number of key cell cycle regulators including the mitotic cyclins (16, 37) , the p53 tumor suppressor (34, 35) , and the c-Jun transactivator (44) . In the yeast Saccharomyces cerevisiae, this system has been shown to be functionally important in at least three of the five stages that define the cell cycle: G 0 to G 1 , G 1 to S, and G 2 to M. The requirement for Ub-dependent proteolysis at each of these stages has been inferred from mutational studies in S. cerevisiae that demonstrate the dependence of each stage on a different member of a class of proteins referred to as the Ub-conjugating enzymes or E2s. These enzymes mediate the transfer of Ub from the Ub-activating enzyme E1 to their protein targets, thereby tagging them for elimination (14, 20, 22, 24) . Ubc1, for example, mediates the G 0 -to-G 1 transition that accompanies spore germination (38) . Cdc34 (Ubc3) is critically involved in the G 1 -to-S transition (6) , whereas a newly discovered Ub-conjugating enzyme, Ubc9, plays an essential role at mitosis (37) . The present study deals with the G 1 -specific Ub-conjugating enzyme, Cdc34.
The CDC34 gene was originally identified as a conditional cell cycle mutation that arrested cells after the Start regulatory step but before S phase (6) . Cells arrested at the Cdc34-dependent step are therefore unable to proceed with nuclear DNA replication but remain competent to duplicate the spindle pole body and produce buds periodically (6) . The Cdc34 protein consists of the moderately conserved catalytic domain that is characteristic of all Ub-conjugating enzymes and a Cterminal extension or tail that is unique to Cdc34 (18) . The tail of Cdc34 is essential for its cell cycle function and can confer its functional properties on the DNA repair Ub-conjugating enzyme Rad6 when appended to its C terminus (26, 41) . Genetic evidence suggests that the tail mediates the interaction of Cdc34 with itself and other E2s and that this interaction is necessary for its function (41) . This idea has been recently strengthened by the observation that both the cell cycle determinant and the ability of Cdc34 to interact with itself in vitro colocalize to a 29-residue segment of the 125-residue tail (33) .
On the basis of published evidence, several candidates for the target of Cdc34 ubiquitination have been proposed. Tyers et al. have suggested that the histone H1 kinase activity that is associated with the G 1 cyclin Cln3 may be a substrate of Cdc34-dependent proteolysis on the basis of its elevated levels in cdc34 mutants (45) . In related work, it has been found that Cln3 is stabilized by a loss of Cdc34 function (46) . Deshaies et al. have also provided evidence that degradation of another cyclin, Cln2, requires Cdc34 function (8) . McKinney et al. have suggested that the Start regulator, Far1, may be a target of Cdc34 on the basis of the increased levels of phosphorylated Far1 in cells defective for Cdc34 (28) . In addition, Schwob et al. have recently provided strong evidence that the Cdc28 inhibitor p40-Sic1 is the Cdc34 substrate responsible for S-phase inhibition in cdc34 mutant cells (36) . Finally, Kornitzer et al. (27) have recently demonstrated that the rapid turnover of Gcn4, a global regulator of amino acid biosynthesis, depends upon Cdc34. Since Gcn4 function bears no obvious relation-ship with cell cycle regulation, these results indicate that the Cdc34 protein is a multifunctional regulator.
At present, little is known about whether Cdc34 is subject to the same forms of posttranslational regulation that are characteristic of other cell cycle regulators; however, the recent observations that Cdc34 is both phosphorylated (17) and ubiquitinated (4, 17) suggest that posttranslational regulation is likely. In this work, we describe a general positive regulator of Cdc34 which we have called Ubs1 (for Ub-conjugating enzyme suppressor 1).
MATERIALS AND METHODS
Plasmids. Four plasmids were used in the physical and functional characterization of the UBS1 gene. The sequence of the UBS1 gene was determined from a plasmid (p24A1) that contained a 1.77-kb Sau3A fragment cloned into the BamHI site of the high-copy yeast plasmid YEP352 (21) . This fragment was originally derived from a larger genomic fragment contained on the high-copy PMA3A yeast plasmid (described in reference 9) that was isolated in the genetic screen described below. In addition to the coding sequence of UBS1, the Sau3A fragment also contained 630 bp to the 5Ј side of the Met-1 codon and 285 bp to the 3Ј side of the termination codon. The fragment is oriented in YEP352 such that the Met-1 codon lies proximal to the HindIII site of the multiple cloning region.
The UBS1 allele was deleted in selected yeast strains with the integration plasmid pUBS1⌬. This plasmid was constructed by replacing the 1,044-bp BglIIHpaI fragment (containing codons 1 to 219 of UBS1) of p24A1 ( Fig. 1) with the BglII-ClaI fragment (containing the TRP1 gene) derived from plasmid YRP7 (42) . To facilitate the ligation of the ClaI end of the fragment to the HpaI end of the plasmid, the ClaI site was filled in prior to ligation. The replacement of the UBS1 gene with the TRP1 gene results in the deletion of about 80% of the UBS1 coding sequence.
For expression experiments involving Ubs1, an expression plasmid (SP2) in which the UBS1 coding sequence was placed under the control of the copperinducible CUP1 promoter was constructed. This high-copy plasmid contains the TRP1 selectable marker and is identical to the Ub expression plasmid YEP96, except that the UBS1 coding sequence replaces the Ub-encoding sequence (12) . In addition, a Met codon and a Ser codon were placed in front of the UBS1 gene Met-1 codon, introducing an SstI site within the UBS1 coding sequence.
The high-copy CDC34-TRP1 expression plasmid used in this study has been previously described (41) and is identical to the UBS1 expression plasmid SP2 except that the coding sequence of CDC34 replaced the coding sequence of UBS1. The low-copy cdc34-1 expression plasmid contains the temperature-sensitive (ts) cdc34-1 allele expressed from the CUP1 promoter carried on the low-copy URA3-based plasmid PRS316 (40) . This expression plasmid was constructed in two steps. First, the cdc34-2 allele (obtained from strain mGG16 by PCR methods [11] ) was used to replace the wild-type CDC34 gene in the CDC34-TRP1 plasmid described above (41) . Second, the CUP1 promoter, cdc34-1 allele, and the CYC1 terminator were removed from the TRP1 high-copy plasmid by BamHI-ClaI digestion and ligated into the BamHI-ClaI sites of the centromere-based plasmid PRS316 (40) . The low-copy cdc34-2 expression plasmid was prepared as described for the cdc34-1 expression plasmid except that the yeast strain YL10 was used as a source of the cdc34-2 allele (32). The low-copy cdc34-3 expression plasmid is also based on the PRS316 plasmid used to construct the low-copy cdc34-1 and cdc34-2 plasmids. The cdc34-3 allele, however, unlike the cdc34-1 and cdc34-2 alleles, was not obtained from mutant chromosomal genes but rather was produced by site-directed mutagenesis of a wild-type CDC34 gene cassette. Specifically, the cdc34-3 allele was prepared with a mutagenic oligonucleotide (ggatggtaga tagccggcgt aaatcgaaac tgtggtggtt tattgggaaa gtcttccgga aattccattt gagc), the wild-type CDC34 gene, and the vectors and conditions described for the Altered States in vitro mutagenesis system (Promega). Successful conversion of the wild-type CDC34 gene to the cdc34-3 mutant allele was confirmed by sequence analysis. The three ts cdc34 mutations were caused by Pro-71-to-Ser substitution associated with the cdc34-1 mutation (11); the Gly-58-to-Arg mutation associated with the cdc34-2 mutation (32); and the Arg-65-to-Glu, Phe-72-to-Asn, and Ser-73-to-Lys substitutions associated with the cdc34-3 mutation.
The pES13 plasmid, which was used as a negative control in experiments with expression plasmids containing the TRP1 selectable marker, is identical to YEP96 except that the coding sequence of the Ub gene was deleted between the unique BglII and SalI sites. The YEP352 plasmid (21) was used as a negative control in examining the effect of URA3-based expression vectors.
The stability of the Gcn4 protein was assessed in S. cerevisiae by a fusion of the GCN4 and lacZ coding sequences under control of the galactose-inducible GAL1 promoter. GCN4 was placed under control of the GAL1 promoter by cloning the HindIII-EcoRI fragment of YCp88-GCN4 (23) into vector pDAD1 (kindly provided by D. Miller and D. Pellman), to generate pGAL-GCN4. For the GCN4-lacZ fusion, PCR methods were used (2) to clone a DNA fragment carrying the complete GCN4 coding sequence under the GAL1,10 promoter from plasmid pGAL-GCN4 into vector YEp357R (30), generating KB64. The details that relate to construction of all these plasmids are available on request.
Yeast strains. Two cdc34 mutant strains were used for the cloning and subsequent functional characterization of UBS1. The ts cdc34-2 mutant strain JP34G2 (MATa ade2-1 his3⌬ leu2⌬1 trp1 ura3-52 cdc34-2) was constructed from a cross of the cdc34-2 mutant strain YL10 (MATa leu2⌬1 his3⌬ trp1⌬63 ura3-53 cdc34-2) and the wild-type strain KMY15 (MATa ade2-1 his3-832 trp1-289 ura3-52). YL10 was obtained from M. Goebl (University of Indiana), and KMY15 was obtained from K. Madura (California Institute of Technology). The CDC34 disruption strain YES71 was created from YL10 by disrupting the cdc34-2 allele with the ApaI-EcoRI fragment from pGEM34H/S as previously described (18) . Viability of YES71 was maintained by the CDC34-TRP1 plasmid (described above) or a low-copy plasmid containing the cdc34-1, cdc34-2, or cdc34-3 allele (described above).
cdc34 mutant and wild-type strains that carried a deletion of the UBS1 allele were constructed by integrating the BglII-HpaI fragment carrying the TRP1 gene from the pUBS1⌬ plasmid (described above) into the UBS1 allele of JP34G2 (cdc34-2) and KMY15 (wild-type CDC34). TRP1 prototrophs from the correct integration of the UBS1⌬-TRP1 fragment at the UBS1 locus were selected on the basis of two criteria: (i) the presence of a unique XbaI site at the UBS1 locus that accompanies the introduction of the TRP1 marker and (ii) the loss of the UBS1 mRNA. In the first method, primers homologous to the 3Ј end of the TYR1 gene (ccgctgatac acaagctgtg acacatgctg) and 5Ј noncoding flank of the UBS1 gene (gaactaaaaa tgttacccat gttgatc) were used in combination with the PCR to obtain 1.2 kb of DNA from the chromosomal UBS1 locus. Successful replacement of the UBS1 gene by the TRP1 gene results in the insertion of a unique XbaI site (from the TRP1 gene) into the center of this DNA fragment. Therefore, sensitivity of the above-mentioned PCR product to XbaI digestion indicates the replacement of the UBS1 gene by the TRP1 gene.
In the second method, the levels of cellular UBS1 mRNA were measured by reverse transcription followed by the specific amplification of a segment of UBS1 cDNA by PCR. In the first step, total RNA was isolated by hot phenol extraction (2) from cells suspected to contain a disruption of the UBS1 gene. With a cDNA primer specific for the UBS1 transcript (gtggctttga gcattgtaag), a cDNA strand was prepared from the RNA template as described previously (31) . In the second step, PCR was performed with these cDNA products and primers specific for the UBS1 gene (UBS1-specific primer above and gtggtgtacgagcc caggacttct). The absence of the expected amplified 437-bp fragment relative to wild-type cells indicated the loss of UBS1 gene function. Yeast strains fulfilling both of the criteria (described above) have been designated JP34G2-UBS1⌬ and KMY15-UBS1⌬.
Gcn4 stability was measured in the wild-type yeast strain KY130 and the isogenic cdc34-2 mutant strain KY203 (27) under conditions described below.
Isolation of high-copy suppressors of the cdc34-2 mutation. To identify highcopy suppressors of the cdc34-2 mutation, cells from strain JP34G2 were transformed with a genomic library on the high-copy vector PMA3A (constructed by Mick Tuite, University of Kent). This library contained 10-to 15-kb Sau3A fragments of yeast genomic DNA ligated into the BamHI site of the LEU2-based plasmid PMA3A (described in reference 9). Suppressor plasmids were identified by their ability to allow cdc34-2 mutant cells to form colonies on yeast extractpeptone-dextrose (YEPD) plates (39) at a restrictive temperature of 32ЊC. This temperature was found to confer slow growth on cdc34 mutants and was chosen so as not to exclude weak suppressors from the selection. Plasmids were isolated from temperature-resistant yeast cells and transformed into Escherichia coli cells. Plasmids propagated in E. coli were amplified, purified, and reintroduced into cdc34-2 mutant cells in order to confirm their suppressor ability. Plasmids still competent to suppress the cdc34-2 mutation after this second selection were grouped into families on the basis of restriction and Southern analysis (2) . Subcloning of each suppressor gene was performed by partial Sau3A digestion of a single plasmid isolate from each family (2) followed by ligation of these fragments into the BamHI site of the shuttle vector YEP352 (21) . Sublibraries were then retransformed into the cdc34-2 mutant strain to identify plasmids with the smallest DNA inserts still able to suppress the cdc34-2 mutation. Selected plasmids were reisolated from S. cerevisiae and sequenced. Sequencing of double-stranded plasmid DNA by the dideoxy chain-termination method was performed on an Applied Biosystems automated Sequenator operated by the University of Alberta DNA Sequencing and Synthesis Facility. The UBS1 gene was sequenced in both strands and searched against the GenBank DNA and protein database. A perfect nucleotide match was found against an unidentified open reading frame (ORF) (SBR165W) that was identified during the sequencing of chromosome II (13) .
Effect of UBS1 overexpression on the relative abundance of the Cdc34-2 protein. The effect of UBS1 overexpression on the abundance of the Cdc34-2 protein was examined in cdc34-2 mutant cells at both the permissive and nonpermissive temperatures. Briefly, log-phase JP34G2 cells, containing either the UBS1 overexpression plasmid (p24A1) or a negative control plasmid (YEP352), were shifted from the permissive temperature of 25ЊC to the nonpermissive temperature of 34ЊC. Cells were harvested before the temperature shift and after 3 h at the nonpermissive temperature. Conditions used for the preparation of protein extracts, gel electrophoresis, and Western blotting (immunoblotting) have been previously described (17) . The Cdc34-2 protein was localized by probing an immunoblot with an anti-Cdc34 antibody (17) and visualized by using the enhanced chemiluminescence Western detection system (Amersham). Total protein determinations of cell lysates were performed by the Bio-Rad assay, and 20 g of protein was loaded into each gel lane. Comparison of band intensities was performed with a Color OneScanner (Macintosh) and MacBas version 2.0 software with an autoradiogram falling within the linear range of exposure.
Suppression analysis of the UBS1 gene in cdc34 mutant strains. The ability of the UBS1 gene to suppress ts cdc34 mutations was assessed both in the cdc34-2 strain JP34G2 and in strain YES71 (with cdc34 deleted) carrying a plasmid with either the cdc34-1, cdc34-2, or cdc34-3 ts allele. When the JP34G2 strain was used, the UBS1 gene was expressed from either the TRP1-UBS1 plasmid SP2 or the URA3-UBS1 plasmid p24A1. Overexpression of the UBS1 gene in the YES71 strain was assessed by using the SP2 plasmid. The important difference between plasmids SP2 and p24A1 is that plasmid p24A1 expresses the UBS1 gene from the native UBS1 promoter, while plasmid SP2 expresses the UBS1 gene from the CUP1 promoter.
The ability of UBS1 overexpression to suppress the cdc34 proliferation defect was assessed by colony formation on YEPD plates or growth in broth (39) at specific nonpermissive temperatures. The nonpermissive temperature for either the cdc34-2 mutant strain or the deletion strain (YES71) expressing one of three cdc34 ts alleles was chosen as the lowest restrictive temperature at which mutant cells were still unable to form visible colonies after 3 days of incubation. By this criterion, the nonpermissive temperature for the cdc34-2 mutant strain was 34ЊC, while the deletion strain had a nonpermissive temperature of 37ЊC when expressing the cdc34-1 and cdc34-2 alleles and 38ЊC when expressing the cdc34-3 allele. At 38ЊC, cdc34-3 mutant cells are still able to form colonies but grow more slowly than wild-type cells and display the cdc34 mutant phenotype.
Cultures of cdc34 mutant cells displaying a multibudded or aberrant cell cycle morphology were prepared by incubating JP34G2 cells in a temperature-controlled water bath in either YEPD or fully supplemented SC broth (39) . Cells were fixed by removing aliquots from these liquid cultures and adding them to a ninefold excess of 0.08% saline and 3% formaldehyde (19) . After cells were fixed, loosely attached cells were separated by sonication with a Vibra-Cell sonicator (Sonics and Materials, Danbury, Conn.) at 50% power for 10 s. The frequency of cells displaying a particular cell morphology was determined by microscopic examination of at least 100 cells for each time point. Analysis of Gcn4 stability was determined as described previously (27) .
RESULTS
Isolation of the UBS1 gene as a high-copy suppressor of the cdc34-2 mutation. In this study, a genetic screen was employed to identify genes that when overexpressed could increase Cdc34 activity. We reasoned that suppressors able to increase Cdc34 activity could function in at least one of three ways. First, overexpression of a protein that normally interacts with Cdc34 might suppress the cdc34-2 mutation by stabilizing the temperature-labile Cdc34-2 protein. Second, overexpression of proteins that normally prevent turnover or inactivation of the Cdc34-2 protein could also suppress the cdc34-2 mutation. Finally, overexpression of a protein that down-regulated the levels of the putative Cdc34 cell cycle target might also be expected to suppress the defect associated with the cdc34-2 mutation. With these mechanisms in mind, high-copy suppressors of the cdc34-2 mutation were identified by their ability to enhance mutant cell growth at the normally restrictive temperature of 32ЊC. From approximately 80,000 transformed cells, 28 colonies were selected. On the basis of Southern analysis, the library plasmids that were isolated from those colonies defined three plasmid families. The first plasmid family had 16 members and was shown to contain the wild-type CDC34 gene. The second family contained five members and by sequence analysis was found to contain the poly-Ub gene, UBI4. The suppression of the cdc34-2 mutation by the UBI4 gene is the subject of another report (32) . The third plasmid family, with seven independent isolates, contained a novel gene which is the subject of this paper.
A representative plasmid from this third family, pI2, was subcloned by partial Sau3A digestion to generate a series of plasmids with different-size DNA fragments (Materials and Methods). From this series, a plasmid (p24A1) that contained the smallest-sized DNA fragment still able to suppress the cdc34-2 mutation was obtained. This plasmid was used in some expression studies and as a template for sequencing. The sequence of the Sau3A fragment contained on plasmid p24A1 revealed one major ORF of 831 bases positioned in the center of the 1.77-kb genomic fragment that encodes a 32.2-kDa polypeptide (Fig. 1) . We have named this ORF UBS1 for Ubconjugating enzyme suppressor 1. By using the Blast protein and DNA database searching service (1), UBS1 was found to be identical to sequence YBR165w, an ORF of unknown function identified during the sequencing of chromosome II (13) .
The UBS1 promoter region was searched against both transcription factor (15) and eukaryotic promoter (Blast program [1] ) databases. Outside of putative TATA boxes and cap-binding sites within 140 bases of the start codon, no previously described transcription factor recognition sequences were found in the UBS1 promoter region.
Ubs1 is a positive effector of Cdc34's cell cycle activity. To establish that the UBS1 gene on plasmid p24A1 encoded the cdc34-2 suppressor, an expression plasmid that placed only the UBS1 coding sequence under the regulation of the CUP1 copper-inducible promoter was created (Materials and Methods). cdc34-2 mutant cells (JP34G2) transformed with this expression plasmid (SP2) and plated at the nonpermissive temperature of 34ЊC were able to form visible colonies after 3 days of incubation (Fig. 2) . In contrast, cdc34-2 mutant cells not overexpressing the UBS1 gene were unable to form visible colonies under these conditions. In subsequent experiments, the UBS1 gene was found to suppress the cdc34-2 mutation as effectively as the entire original genomic fragment (data not shown). Therefore, the UBS1 gene encodes a polypeptide able to suppress the cdc34-2 mutation.
In JP34G2 cells (cdc34-2), increased expression of the UBS1 gene by induction of the copper promoter (CUP1) with CuSO 4 did not increase the suppressor ability of the expression plasmid with respect to the original genomic plasmid p24A1 (data not shown). This observation indicates that the optimal level of expression of the UBS1 gene necessary to suppress the cdc34-2 VOL. 16, 1996 Ubs1 SUPPRESSES cdc34 MUTATIONS 679
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Other cell cycle phenotypes associated with the cdc34 mutation are also suppressed by the UBS1 gene. One cdc34 mutant phenotype originally associated with the cell proliferation defect is the formation of cells with multiple buds in cultures incubated at restrictive temperatures (6) . As shown in Fig. 3 , overexpression of the UBS1 gene reduces by fourfold the frequency of multibudded cells in cdc34-2 cultures (strain JP34G2) incubated at the restrictive temperature of 34ЊC. This reduction in the frequency of multibudded cells is seen whether the UBS1 gene is expressed from its native promoter or the CUP1 promoter (data not shown). These results demonstrate that overexpression of the UBS1 gene suppresses both the proliferation defect associated with the cdc34-2 mutation and its associated mutant cell phenotype.
The results described above show that overexpression of the UBS1 gene can partially suppress cellular defects associated with a loss of Cdc34 function. We next examined the effect on the cell cycle produced by deleting the UBS1 gene from either wild-type cells or cdc34-2 mutant cells. Deletion of the UBS1 gene in a wild-type strain (KMY15) had no effect on viability, and cells were morphologically indistinguishable from wildtype cells with an intact UBS1 gene. Furthermore, these cells displayed none of the other obvious phenotypes normally associated with defects in Ub conjugation, including temperature and canavanine sensitivity (38) , sensitivity to UV light (25) , or a defect in either sporulation or germination (25, 38) . Therefore, the UBS1 gene appears to be nonessential when present in a wild-type CDC34 background. In sharp contrast, however, cdc34-2 mutant cells that had lost Ubs1 function displayed extremely poor cell viability and slow growth at room temperature, 9ЊC lower than the normal nonpermissive temperature for cdc34-2 mutant cells. Microscopic examination revealed that a large portion of these cells express a multibudded mutant phenotype normally seen in cdc34-2 mutant cells after incubation at the nonpermissive temperature (Fig. 4D) . Since cdc34-2 mutant cells do not normally display these mutant phenotypes at the permissive temperature of 25ЊC, these results indicate that a loss of Ubs1 function causes a significant decrease in Cdc34-2 activity. As expected, the enhanced cdc34 mutant phenotype caused by deletion of the UBS1 gene can be reversed by introduction of the UBS1 overexpression plasmid (data not shown).
Although the UBS1 gene is not essential for wild-type cells under the range of conditions tested, the suppression of cdc34-2 mutants by elevated levels of the Ubs1 protein coupled with the heightened severity of the Cdc34-2 phenotype upon loss of Ubs1 strongly correlates the Ubs1 protein with a normal role in Cdc34 function.
UBS1 overexpression does not alter the relative abundance of the Cdc34-2 protein. In earlier studies, we found that either increased gene dosage or transcription of ts cdc34 alleles resulted in the suppression of the ts defect normally associated with that particular allele (data not shown). This loss of temperature sensitivity is likely caused by an increase in the abundance of the partially functional Cdc34 mutant protein which   FIG. 2 . Overexpression of the UBS1 gene suppresses the cell proliferation defect associated with the cdc34-2 mutation. JP34G2 cells (cdc34-2) transformed with either the UBS1 or CDC34 expression plasmid or the negative control plasmid PES13 were streaked on YEPD plates and incubated for 3 days at 34ЊC .   FIG. 3 . Overexpression of the UBS1 gene reduces the frequency of multibudded cells in cdc34-2 mutant cell cultures incubated at the nonpermissive temperature. Log-phase cultures of JP34G2 cells (cdc34-2) with (cdc34-2 ϩ UBS1) or without (cdc34-2) the UBS1 plasmid were shifted from 25ЊC to the nonpermissive temperature of 34ЊC. Cells were then collected from log-phase cultures at 2-h intervals and fixed, and the frequency of multibudded cells was determined by microscopic examination. in turn leads to increased cellular levels of Cdc34 activity. To determine if UBS1 suppression operates by a mechanism that increases the level of Cdc34-2, we directly examined the abundance of the Cdc34-2 protein in cells overexpressing the UBS1 gene. In these experiments, log-phase cultures of cdc34-2 mutant cells, with or without the UBS1 overexpression plasmid, were harvested either at the permissive temperature of 25ЊC or after 3 h at the nonpermissive temperature of 34ЊC. Examination of immunoblots prepared with total cellular protein and probed with an anti-Cdc34 antibody showed that the level of the Cdc34-2 protein in cells overexpressing the UBS1 gene was indistinguishable from the level of the Cdc34-2 protein in the absence of UBS1 overexpression when incubated at the nonpermissive temperature (Fig. 5) . Therefore, the mechanism by which Ubs1 suppresses the cdc34-2 mutation does not involve an increase in the abundance of the Cdc34-2 protein by either a transcriptional, translational, or posttranslational process. UBS1 overexpression can partially restore the ability of cdc34 mutant cells to degrade Gcn4. A recent report has shown that Cdc34 is involved in the ubiquitination and turnover of the general amino acid control protein Gcn4 (27) . Since mutations that influence Gcn4 activity exhibit none of the cell cycle defects associated with cdc34 mutations, it is clear that Gcn4 represents a target of Cdc34 that is functionally unrelated to the cell cycle phenotypes associated with cdc34 mutants. To test whether UBS1 overexpression can influence Gcn4 turnover, we examined the half-life of a Gcn4-␤-galactosidase fusion protein (27) expressed in wild-type or cdc34-2 mutant cells in the presence or absence of the high-copy UBS1 plasmid. The results of this experiment are shown in Fig. 6 . In wild-type cells Gcn4-␤-galactosidase was degraded at 34ЊC with an estimated half-life of 3 min. In contrast, the half-life of Gcn4-␤-galactosidase in cdc34-2 mutant cells increased 13-fold to 40 min. Introduction of the UBS1 plasmid into these cells, however, resulted in a relative threefold stabilization of Gcn4-␤-galactosidase, yielding a half-life of approximately 14 min. Thus, UBS1 overexpression partially suppresses the Gcn4 turnover defect associated with loss of Cdc34 function and is therefore not restricted to an exclusive role in the cell cycle.
The Ubs1 protein exhibits similarity to a defined region on the surface of Ub-conjugating enzymes. A comparison of the Ubs1 polypeptide sequence with the SwissProt database revealed similarity to the previously characterized wheat Ubconjugating enzyme Ubc1 (accession number P25856 [43] ). Upon visual inspection, these regions of similarity were also found on the Cdc34 protein. The similarity of Ubs1 to these Ub-conjugating enzymes is confined to two short noncontiguous regions we have called A and B (Fig. 7) . With regard to Ubs1, region A exhibits 65% similarity with Cdc34 and 79% with Ubc1. In region B, Ubs1 shows 74% similarity with Cdc34 and 76% with Ubc1. Percent similarity was computed by assigning a numerical similarity value to each pair of amino acids aligned within regions A and B (3). A total of these values was expressed as the percentage of a hypothetical score obtained by perfectly matched residues. On the basis of these analyses, we conclude that the region of similarity shared between Ubs1 and either Ubc1 or Cdc34 is significant.
From the similarity analysis and using the previously determined crystallographic structure of the Arabidopsis Ubc1 protein (7) as a model of Cdc34, we have mapped these two regions onto its three-dimensional structure (Fig. 8) . Although these regions are separated from one another in the Cdc34 primary sequence by 14 residues and in the Ubs1 primary sequence by 66 residues, they fold in three dimensions to produce a defined patch on the surface of the conjugating enzyme. Interestingly, the cdc34-2 substitution which is nor- VOL. 16, 1996 Ubs1 SUPPRESSES cdc34 MUTATIONS 681 mally suppressed by UBS1 lies outside of the Ubs1-related patch. We reasoned therefore that if this region functioned in UBS1 suppression, then amino acid substitutions made within this region should be detrimental to Cdc34 in a manner that could not be suppressed by UBS1. To test this idea, we examined the behavior of the cdc34-1 allele carrying a single substitution situated within the patch (Pro-71 to Ser) and a newly created cdc34 derivative (cdc34-3) carrying three substitutions within the patch (Arg-65 to Glu, Phe-72 to Asn, and Ser-73 to Lys). To minimize possible perturbations to the structure of Cdc34, substitutions were confined to positions situated on the surface and correspond to residues found in another yeast E2 of different function, Ubc2. Upon examining cdc34 mutant cells at their allele-specific nonpermissive temperatures (Materials and Methods), UBS1 overexpression was found to reduce the frequency of multibudded cells by 74, 7, and 0% for the cdc34-2, cdc34-1, and cdc34-3 mutant alleles, respectively. Therefore, UBS1 could suppress the cdc34-2 mutation readily, the cdc34-1 allele only poorly, and the cdc34-3 allele not at all. Thus, UBS1 shows allele-specific suppression of ts cdc34 alleles and specifically an impaired ability to suppress cdc34 mutations that reside within the region of similarity that Cdc34 shares with Ubs1. Significantly, the phenotypic effects of the cdc34-3 allele are less severe than those of cdc34-1 or cdc34 alleles even though it bears the greatest mutational load. Therefore, the allele specificity exhibited by UBS1 expression does not correlate with the strength of the mutant phenotype. On the basis of this observation, we conclude that the allele-specific behavior of UBS1 expression reflects a mechanistic link between Cdc34 and Ubs1 in which the region of similarity between these proteins plays a key role.
DISCUSSION
In the present work, we describe a new yeast gene, UBS1, whose function is mechanistically linked to the function of Cdc34. The evidence that establishes the functional relationship between Ubs1 and Cdc34 is based on two observations. UBS1 overexpression suppresses both the cell cycle and Gcn4 turnover defects of a cdc34 ts mutant. Conversely, the deletion of UBS1 greatly accentuates the defects associated with this mutant. UBS1 expression therefore has a positive effect on processes that are directly related to Cdc34 function.
The mechanistic link between the Ubs1 and Cdc34 proteins is based on several pieces of evidence which demonstrate that UBS1 expression posttranslationally modifies the activity of the Cdc34 polypeptide. First, the fact that UBS1 expression directly affects the turnover of Gcn4 (Fig. 6) illustrates that Ubs1 positively influences Cdc34-dependent proteolysis, thereby discounting less direct mechanisms of suppression including the possibility that UBS1 expression lowers the levels of Cdc34 targets by nonproteolytic means or alternatively that UBS1 expression somehow bypasses the need to target these substrates altogether. Second, the observation that Ubs1 expression has no effect on the steady-state levels of Cdc34-2 (Fig. 5) at the nonpermissive temperature indicates that UBS1 expression contributes to the activity of the Cdc34 polypeptide, without altering its intracellular levels. Finally, although Ubs1 and Cdc34 exhibit no overall similarity to one another, they do hold structural attributes in common. Ubs1 exhibits significant similarity to a defined patch on the surface of Cdc34. Whereas cdc34 mutations that are unrelated to the patch are suppressed by UBS1 expression, mutations that affect the patch lose their dependence on Ubs1. Thus, the functional relationship between Cdc34 and Ubs1 correlates well with their limited structural similarity.
It is unlikely that Ubs1 functions redundantly as an E2 that functionally overlaps with Cdc34, on the basis of two observations. With the exception of the limited similarity between Ubs1 and Cdc34 already discussed, Ubs1 shares no significant similarity with the conserved catalytic domains of any E2 identified to date. Furthermore, if Ubs1 exhibited some of the catalytic properties of Cdc34, it would be expected to exert its suppressive effects on all three of the cdc34 mutant alleles examined here. This notion is clearly at odds with the allelespecific behavior observed for Ubs1.
Suppressive effects that are allele specific have often been cited as genetic evidence for the physical interaction of the suppressor and mutant protein (5, 29) . Although we cannot rule out an interaction between Ubs1 and Cdc34, we have been FIG. 7 . Two regions of Ubs1 exhibit strong similarity to the Ub-conjugating enzymes Cdc34 and wheat Ubc1. The upper portion of this figure represents the linear peptide sequence of the Ubs1 and Cdc34 proteins, showing the relative sizes and positions of the similar regions (black boxes). The lower portion of this figure displays an alignment of these regions for Cdc34, wheat Ubc1, and Ubs1. The region closest to the amino terminus represents residues 34 to 47 of Cdc34 (18), 28 to 41 of Ubc1 (43) , and 31 to 44 of Ubs1. The second region represents residues 62 to 80 of Cdc34, 55 to 73 of Ubc1, and 111 to 129 of Ubs1. A perfect residue match between sequences is indicated by a vertical line, whereas nonidentical conservation between sequences is indicated by a plus sign. Amino acid substitutions caused by the cdc34-1 and cdc34-3 mutations are indicated below the wild-type Cdc34 sequence.
FIG. 8. Three-dimensional location of the region of similarity shared between the Cdc34 and Ubs1 proteins. Shown is a CPK and ribbon image of Arabidopsis Ubc1-conjugating enzyme (7) used here as a model of the Cdc34 catalytic domain. Indicated in pink is the region of similarity between Cdc34 and Ubs1 as described for Fig. 7 ; the catalytic cysteine residue is indicated in yellow. The position of the cdc34-1 substitution (Pro-71 to Ser) is indicated in red.
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unable to detect their interaction either in vitro or with the two-hybrid system (results not shown). There is, however, an equally plausible alternative that is consistent with the data presented here and can account for the suppressive behavior of UBS1. Cdc34 and Ubs1 may independently interact with an inactivator of Cdc34 via the patch they hold in common. Increased expression of UBS1 would be expected to sequester the inactivator, thereby elevating the levels of active Cdc34. Experiments to test this hypothesis are under way. Recently, we have found that the region corresponding to the Ubs1-Cdc34 patch in other E2s plays a role in determining their functional distinctiveness. This evidence is based on our observation that transposition of amino acid positions within the B region of the Rad6 protein with their Ubc4 counterparts confers partial Ubc4 function on Rad6 (unpublished data). The temperature sensitivity of the Cdc34-3 polypeptide that results from surface substitutions in the same region is consistent with this view. The possibility that a structural determinant of E2 specificity may also contribute to its regulation would provide a logical and attractive means for differential E2 regulation. We thank S. Smith for secretarial assistance.
